ClinVar Miner

Submissions for variant NM_000162.5(GCK):c.183C>A (p.Tyr61Ter)

dbSNP: rs780612692
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Mendelics RCV000987868 SCV001137352 pathogenic Maturity-onset diabetes of the young type 2 2019-05-28 criteria provided, single submitter clinical testing
Geisinger Clinic, Geisinger Health System RCV000987868 SCV002562164 pathogenic Maturity-onset diabetes of the young type 2 2022-08-02 criteria provided, single submitter research PVS1, PM2, PP1_Strong, PS4, PP4
Ambry Genetics RCV002409317 SCV002710949 pathogenic Maturity onset diabetes mellitus in young 2019-10-24 criteria provided, single submitter clinical testing The p.Y61* pathogenic mutation (also known as c.183C>A), located in coding exon 2 of the GCK gene, results from a C to A substitution at nucleotide position 183. This changes the amino acid from a tyrosine to a stop codon within coding exon 2. This mutation was detected in a homozygous permanent neonatal diabetes case, as well as in additional heterozygous family members with hyperglycemia (Rubio-Cabezas O et al. Pediatr Diabetes, 2008 Jun;9:245-9). This mutation has also been reported in a maturity-onset diabetes of the young (MODY) cohort, although clinical details were limited (Estalella I et al. Clin. Endocrinol. (Oxf), 2007 Oct;67:538-46). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Labcorp Genetics (formerly Invitae), Labcorp RCV002549692 SCV003439956 pathogenic not provided 2023-03-01 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Tyr61*) in the GCK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GCK are known to be pathogenic (PMID: 7553875, 9867845, 14578306, 24323243, 25015100). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal dominant maturity onset diabetes of the young or autosomal recessive permanent neonatal diabetes (PMID: 17573900, 18298419, 23009393). ClinVar contains an entry for this variant (Variation ID: 802309). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.